AI-robot guided surgery for large basal ganglia bleeding
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new, less invasive brain surgery using a robotic arm guided by artificial intelligence (AI) to remove a large blood clot caused by a hemorrhagic stroke in the basal ganglia. It may be an option for people who can have surgery soon after the stroke and were previously independent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- The bleeding is in the basal ganglia (deep part of the brain) and caused by high blood pressure
- The bleed is large (at least the size of a golf ball, 30 mL)
- You are still somewhat responsive (able to open eyes, speak, or move on command)
- Surgery can happen within 3 days of the bleeding start
- You were able to do everyday activities without help before this stroke (mRS score 0 or 1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a minimally invasive surgery guided by a robotic AI system can help people with moderate bleeding deep inside the brain (basal ganglia). If you qualify, the surgery would happen within 72 hours of your stroke.
This trial tests a minimally invasive surgery guided by artificial intelligence to treat spontaneous brain bleeding. It aims to improve recovery by precisely removing the clot with less damage to healthy brain tissue.
This trial tests a minimally invasive surgery to drain blood from a bleed in the brain stem. It aims to reduce pressure and improve recovery in patients with severe bleeding who arrive at the hospital quickly.
This trial tests a new, less invasive surgery using a robot to help guide the doctor to drain blood from a brainstem bleed. It may be an option for people who can have surgery soon after the bleed and who have a certain level of consciousness.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial tests a minimally invasive robot-assisted surgery to remove bleeding inside the brain's fluid-filled spaces, which can happen after a stroke or injury. It aims to improve recovery by clearing the blood and reducing pressure on the brain.
Hear when a new Hematoma Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.